ARTICLE | Financial News
BioTime completes direct public offering
October 5, 2015 7:00 AM UTC
BioTime Inc. (NYSE-M:BTX; Tel Aviv:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Date completed: 2015-10-01 Type: Direct public offering Raised: $20.4 million Shares: 6.5 mi...